New test can identify dangerous bacteria with resistance to last-resort antibiotic

April 24, 2017, European Society of Clinical Microbiology and Infectious Diseases

New research suggests it is possible to quickly and accurately diagnose some the most dangerous and drug-resistant types of bacterial infections, using equipment already owned by most hospitals.

Bacteria have been gradually evolving to become resistant to the antibiotics used to treat them. Over the last few year, scientists have found evidence that some have become resistant to a last resort antibiotic called colistin.

Now, in a presentation at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), researchers described how they were able to test bacteria to quickly tell whether they were resistant to colistin, and how easily they might pass this resistance on to other bacteria. They say this is an important discovery because knowing which patients have these most dangerous infections means it is possible to use quarantine measures to halt their spread and stop the rise of drug resistance.

The research was presented by Dr Laurent Dortet, Associate Professor at South Paris University, France, and a researcher at Imperial College London, UK. The work was a collaboration between Dr Dortet and colleagues at Imperial, Dr Gerald Larrouy-Maumus and Professor Alain Filloux.

They studied bacteria called Escherichia coli and Klebsiella pneumoniae. These are both members of a group of bacteria called Enterobacteriacae that can cause gastroenteritis, , lung diseases such bronchitis and pneumonia, and even sepsis.

Some strains of these bacteria have become resistant to nearly all available antibiotics mostly by producing antibiotic inactivating enzymes, for example extended-spectrum -lactamases and carbapenemases. This means that colistin often remains the only treatment option for these . Unfortunately, some have now also developed resistance to colistin.

Previous research has shown two different types of colistin resistance exist in bacteria. One type, called chromosome-encoded resistance, can only be passed on when bacteria grow and divide to form new bacteria cells. The other type, called plasmid-encoded resistance, is considered more dangerous because it can be passed on from one type of bacteria to another completely different type of bacteria.

Dr Dortet told the congress: "This plasmid-encoded resistance is particularly worrying because it has the potential to spread quickly and easily and, if that happens, last resort drugs like colistin could also become obsolete. If, on the other hand, we are able to rapidly identify bacteria that have this type of resistance, we can take measures to stop its spread. This might include isolating the patient in a separate room where they are treated by dedicated medical staff."

The team tested 134 different colonies of bacteria using a machine called a mass spectrometer. Mass spectrometers are found in testing labs at most hospitals where they are used to analyse various different molecules.

They found that it was possible to distinguish not only between those bacteria that are colistin resistant, and those that are not, but also which bacteria have the more dangerous plasmid-encoded resistance. They say the test can be carried out in around 15 minutes and would cost less than one US dollar per sample.

Dr Larrouy-Maumus explained: "The exciting thing about this technique is that it relies on technology that is already available in most hospitals. This means that it could be rolled out quickly and cheaply, and potentially have a rapid impact on tackling drug-resistance."

The researchers are now working with Imperial Innovations, Imperial College London's technology transfer office, to patent the technique and develop it for widespread use in hospital laboratories.

They say the test could also be useful for screening in veterinary samples, where levels of colistin- are known to be high. It might also be used for testing whether new drugs are able restore bacteria's vulnerability to .

Explore further: Q&A: Superbug precursor found in US again

Provided by: European Society of Clinical Microbiology and Infectious Diseases

0 shares

Related Stories

Q&A: Superbug precursor found in US again

July 11, 2016
A New York City patient was infected with bacteria that had a special type of resistance to antibiotics last year, the earliest known case in the U.S. of bacteria that could lead to a superbug impervious to medications.

Multi-drug resistant bacteria in China

January 28, 2017
The mcr-1 gene—a gene that makes bacteria resistant to colistin, an antibiotic of last resort, and that is transferrable between bacteria—has been found in a wide variety of strains of Escherichia coli in China following ...

Rapid test detects mobile resistance gene mcr-1

February 6, 2017
Scientists from the German Center for Infection Research (DZIF) and the Justus Liebig University Giessen (JLU) have evaluated a rapid test that detects the dreaded colistin resistance gene within twenty minutes. It can therefore ...

Drug-resistant bacteria in patients' urine or stools raise risk of drug-resistant sepsis

April 23, 2017
People who have recently been found to have drug-resistant bacteria in their urine or stool samples have a greatly increased risk of developing a bloodstream infection that is also resistant to certain antibiotics, according ...

More cases of superbug precursor reported, but no spread

September 9, 2016
A fourth U.S. person has been diagnosed with bacteria resistant to a last resort antibiotic, but researchers are expressing relief that so far these superbug precursors have not spread to others.

The dirty dozen: UN issues list of 12 most worrying bacteria

February 27, 2017
The World Health Organization has issued a list of the top dozen bacteria most dangerous to humans, warning that doctors are fast running out of treatment options.

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.